Not provided
Not provided
Not provided
Not provided
Not provided
poor recruitment
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Alberta | OTHER |
| Johnson & Johnson Medical Companies | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This randomized multi-centre trial will recruit women with stress urinary incontinence who need surgical treatment for their condition. 300 women will be allocated either to receive a TVT Secur or a standard TVT surgical procedure. The main outcome is effectiveness of the procedure, determined using a 1-hour pad test (which tests for urine leakage) 12 months after surgery. The study will be carried out in 4 to 6 centers and will involve urogynaecologists, urologists and general obstetrician-gynaecologists: all clinicians will have received adequate training.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| TVT Secur surgical device | Experimental | Single incision tape device |
|
| TVT surgical device | Active Comparator | Usual care retropubic tape device |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| TVT Secur (Gynecare) | Procedure | Sling device for stress urinary incontinence |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Standardised pad test: "cure" is defined as less than 1g gain in pad weight over the duration of the test | 12 months following surgery |
| Measure | Description | Time Frame |
|---|---|---|
| Subjective evidence of cure | 12 months following surgery | |
| Incontinence-related quality of life (UDI-6, IIQ-7) | 6 weeks and 12 months following surgery | |
| Sexual function (PISQ-12) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Women who:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Sue Ross, PhD | University of Calgary | Study Director |
| Magali Robert, MD | University of Calgary | Principal Investigator |
| Jane Schulz, MD | University of Alberta | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Foothills Medical Centre | Calgary | Alberta | T2N 1C5 | Canada | ||
| Royal Alexandra Hospital |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 25532604 | Result | Ross S, Tang S, Schulz J, Murphy M, Goncalves J, Kaye S, Dederer L, Robert M. Single incision device (TVT Secur) versus retropubic tension-free vaginal tape device (TVT) for the management of stress urinary incontinence in women: a randomized clinical trial. BMC Res Notes. 2014 Dec 22;7:941. doi: 10.1186/1756-0500-7-941. |
Not provided
Not provided
The decision to share would depend on the protocol of an IPD analysis protocol
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D014550 | Urinary Incontinence, Stress |
| ID | Term |
|---|---|
| D014549 | Urinary Incontinence |
| D014555 | Urination Disorders |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| TVT (Gynecare) |
| Procedure |
Sling procedure for stress urinary incontinence |
|
| 12 months following surgery |
| Satisfaction with surgical outcome | Patients will be asked about the expectations they had before surgery, and asked if the outcome had met expectations. Women will be asked about satisfaction with the surgical outcome, if they would have the same operation again under the same circumstances, and if they would recommend the same operation to someone else with the same problem. | 12 months following surgery |
| Return to usual activities | up to 12 months following surgery |
| Voiding dysfunction | 12 months following surgery |
| Surgical complications | up to 12 months following surgery |
| Cost | up to 12 momths following surgery |
| Utility (15-D) | 6 weeks and 12 months following surgery |
| Edmonton |
| Alberta |
| T5H 3V9 |
| Canada |
| Penticton Regional Hospital | Penticton | British Columbia | V2A 3G6 | Canada |
| Lions Gate Hospital | Vancouver | British Columbia | V7L 2L7 | Canada |
| D005261 |
| Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D059411 | Lower Urinary Tract Symptoms |
| D020924 | Urological Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |